Supplementary Table S2 from Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia

Autor: Deborah W. Neklason, Philip S. Bernard, Randall W. Burt, Kathryn R. Byrne, Priyanka Kanth, Inge J. Stijleman, Lisa M. Pappas, Kenneth M. Boucher, Kajsa E. Affolter, Wade S. Samowitz, N. Jewel Samadder, Angela K. Snow, Austin C. Wood, Don A. Delker
Rok vydání: 2023
DOI: 10.1158/1940-6207.22533635.v1
Popis: Endpoint only comparisons 3. Endpoint only comparisons (with all polyps, all 20 samples) a. Drug normal to polyp b. Placebo normal to polyp 4. Endpoint only excluding polyps < 50% tumor purity a. Drug normal to polyp b. Placebo normal to polyp
Databáze: OpenAIRE